Keyphrases
Atrial Fibrillation
100%
Adverse Outcomes
100%
Digoxin
100%
Confidence Interval
27%
Adjusted Hazard Ratio
27%
All-cause Mortality
18%
Cardiovascular Mortality
18%
Cardiovascular Hospitalizations
18%
Clinical Practice
9%
Unique Identifier
9%
Cox Proportional Hazards Model
9%
Diabetes Mellitus
9%
High Proportion
9%
Randomized Trial
9%
Serum Concentration
9%
Registry Study
9%
Renal Disease
9%
Clinical Trial Registration
9%
Ablation
9%
Persistent Atrial Fibrillation
9%
High Heart Rate
9%
Chinese Patients
9%
Hospital-based Registry
9%
ChiCTR
9%
History of Heart Failure
9%
Medicine and Dentistry
Atrial Fibrillation
100%
Adverse Outcome
100%
Digoxin
100%
Cardiovascular System
36%
Hazard Ratio
27%
All Cause Mortality
18%
Proportional Hazards Model
9%
Diabetes Mellitus
9%
Heart Failure
9%
Persistent Atrial Fibrillation
9%
Clinical Trial
9%
Catheter Ablation
9%
Nursing and Health Professions
Atrial Fibrillation
100%
Adverse Outcome
100%
Digoxin
100%
Hazard Ratio
27%
Confidence Interval
27%
All Cause Mortality
18%
Clinical Practice
9%
Blood Level
9%
Proportional Hazards Model
9%
Diabetes Mellitus
9%
Heart Failure
9%
Persistent Atrial Fibrillation
9%
Pharmacology, Toxicology and Pharmaceutical Science
Atrial Fibrillation
100%
Adverse Outcome
100%
Digoxin
100%
All Cause Mortality
18%
Clinical Trial
9%
Diabetes Mellitus
9%
Heart Failure
9%
Persistent Atrial Fibrillation
9%
Biochemistry, Genetics and Molecular Biology
Digoxin
100%
Atrial Fibrillation
100%
All Cause Mortality
18%
Clinical Trial
9%
Blood Level
9%